Jacob Strahilevitz
Overview
Explore the profile of Jacob Strahilevitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
1791
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marano R, Oster Y, Benenson S, Motro Y, Ayalon O, Rosenbluh C, et al.
J Infect Dis
. 2025 Mar;
PMID: 40036400
Carbapenemase-producing Enterobacterales (CPE) pose a major healthcare challenge. We report the first hospital outbreak of Pseudocitrobacter faecalis carrying blaNDM-1 using an omics-based approach. Short- and long-read sequencing enabled genomic epidemiological...
2.
Goldstein A, Neuberger A, Darawsha Y, Hussein K, Shafat T, Grupel D, et al.
Sci Rep
. 2024 Jul;
14(1):16985.
PMID: 39044026
Covid-19 disease is implicated in increased mortality among immunocompromised patients. The JAK inhibitor, baricitinib (bar), or the IL-6 inhibitor, tocilizumab (toc), demonstrated a survival benefit in patients with severe disease.However,...
3.
Strahilevitz J, Motro Y, Temper V, Merezhko D, Ayalon O, Bar Moshe Y, et al.
Antimicrob Agents Chemother
. 2024 Jul;
68(8):e0066324.
PMID: 38990012
Non-carbapenemase-producing carbapenem-resistant (non-CP CRE) may be associated with a grave outcome. The common underlying mechanism is beta-lactamases and mutations in outer membrane porins. We report a case of a deep-seated...
4.
Motro Y, Temper V, Strahilevitz J, Moran-Gilad J
Eur J Clin Microbiol Infect Dis
. 2024 May;
43(8):1645-1650.
PMID: 38811483
E. innesii is a recently described Enterococcus species which may be difficult to differentiate from the more common E. casseliflavus. We present the first clinical report of invasive E. innesii...
5.
Bar Ziv O, Cahn A, Jansen T, Istomin V, Kedem E, Olshtain-Pops K, et al.
J Infect Dis
. 2024 Apr;
230(2):411-420.
PMID: 38557867
Diabetes mellitus (DM) is more common among people living with human immunodeficiency virus (PLWH) compared with healthy individuals. In a prospective multicenter study (N = 248), we identified normoglycemic (48.7%),...
6.
Truong-Bolduc Q, Liao C, Nakaminami H, Strahilevitz J, Leanse L
Front Microbiol
. 2024 Mar;
15:1387518.
PMID: 38486700
No abstract available.
7.
Mekayten M, Heifetz E, Sompolinsky Y, Lorber A, Duvdevani M, Strahilevitz J
Urolithiasis
. 2023 Sep;
51(1):116.
PMID: 37747535
No abstract available.
8.
Mekayten M, Heifetz E, Sompolinsky Y, Lorber A, Duvdevani M, Strahilevitz J
Urolithiasis
. 2023 Aug;
51(1):110.
PMID: 37634153
Endourological procedures are the mainstay of treatment for stone disease in the upper urinary system. Infection is a common complication, and urine cultures (UC) are often obtained preoperatively. In this...
9.
Pikkel-Geva H, Grisariu S, Rivkin M, Stepensky P, Strahilevitz J, Averbuch D, et al.
Clin Transplant
. 2023 Aug;
37(11):e15098.
PMID: 37563430
Objectives: The gastrointestinal (GI) tract is a major human adenovirus (HAdV) replication site in patients undergoing hematopoietic stem cell transplantation (HSCT), yet the prevalence and correlates of HAdV GI infection...
10.
Kleinhendler E, Cohen M, Moses A, Paltiel O, Strahilevitz J, Cahan A
Int J Antimicrob Agents
. 2023 Aug;
62(3):106928.
PMID: 37537004
No abstract available.